Valuation: Labcorp Holdings Inc.

Market Cap 2.98TCr 2.66TCr 2.44TCr 2.22TCr 4.21TCr 2,79000Cr 4.31TCr 29TCr 12TCr 1,49400Cr 11TCr 11TCr 4,70400Cr P/E 2026 *
27x
P/E 2027 * 24.3x
Enterprise Value 3.49TCr 3.12TCr 2.87TCr 2.6TCr 4.94TCr 3,27400Cr 5.06TCr 34TCr 14TCr 1,75300Cr 13TCr 13TCr 5,52100Cr EV / Sales 2026 *
2.36x
EV / Sales 2027 * 2.2x
Free-Float
99.65%
Yield 2026 *
0.79%
Yield 2027 * 0.8%
1 day+1.66%
1 week+4.74%
Current month+3.06%
1 month+19.32%
3 months+15.92%
6 months+46.02%
Current year+48.46%
1 week 350.66
Extreme 350.66
373.34
1 month 310.11
Extreme 310.11
373.34
Current year 245
Extreme 245
373.34
1 year 245
Extreme 245
373.34
3 years 191.97
Extreme 191.97
373.34
5 years 191.97
Extreme 191.97
373.34
10 years 98.02
Extreme 98.02
373.34
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Technology Officer

3,000 0.0037%
01/09/26 Free

Chief Technology Officer

750 0.0009%
01/09/26 Free

EVP, COO

900 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+1.66%+4.74%+42.63%+82.33% 2.98TCr
+1.45%-3.92%+9.67%+27.42% 11TCr
+1.96%+7.97%+9.95%+121.92% 10TCr
+2.61%-15.83%+54.35%+602.64% 4.5TCr
0.00%+9.80%+10.16%+103.96% 3.3TCr
+1.32%+3.14%+40.35%+96.51% 2.81TCr
+3.02%+9.01%+50.56%+456.61% 2.25TCr
-0.37%+0.09%-19.78%-19.41% 2TCr
-0.26%-1.91%-7.00%+28.33% 1.68TCr
+2.26%+3.52%+104.33% - 1.4TCr
Average +1.37%-1.57%+29.52%+166.70% 4.2TCr
Weighted average by Cap. +1.55%-2.46%+22.23%+151.92%

Financials

2026 *2027 *
Net sales 1.48TCr 1.32TCr 1.22TCr 1.11TCr 2.09TCr 1,39000Cr 2.15TCr 15TCr 5.81TCr 74TCr 5.57TCr 5.45TCr 2,34300Cr 1.56TCr 1.39TCr 1.28TCr 1.16TCr 2.21TCr 1,46500Cr 2.26TCr 15TCr 6.12TCr 78TCr 5.86TCr 5.74TCr 2,47000Cr
Net income 111.15Cr 99Cr 91Cr 83Cr 157.02Cr 10TCr 160.92Cr 1.09TCr 435.28Cr 5.58TCr 417.18Cr 408.26Cr 18TCr 121.77Cr 108.69Cr 100.02Cr 91Cr 172.03Cr 11TCr 176.3Cr 1.2TCr 476.88Cr 6.11TCr 457.05Cr 447.28Cr 19TCr
Net Debt 516.86Cr 461.35Cr 424.52Cr 385.29Cr 730.18Cr 48TCr 748.3Cr 5.08TCr 2.02TCr 26TCr 1.94TCr 1.9TCr 82TCr 459.42Cr 410.08Cr 377.35Cr 342.48Cr 649.04Cr 43TCr 665.15Cr 4.51TCr 1.8TCr 23TCr 1.72TCr 1.69TCr 73TCr
Projected Income Statement - Annual - Labcorp Holdings Inc.
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
10/26/10 $372.43 +1.60% 4,15,670
06/26/06 $366.57 +0.90% 6,10,114
05/26/05 $363.30 -1.22% 7,75,272
04/26/04 $367.79 +3.92% 8,09,673
03/26/03 $353.92 -0.47% 7,17,240
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Labcorp Holdings Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
366.57USD
Average target price
390.06USD
Spread / Average Target
+6.41%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Labcorp Holdings Inc.